Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,206 recalls · Class II, newest first

Class II · Moderate risk

Proton Armor

Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.

Terminated Chemical / undeclared Ultra Chem Labs Corp NDC 79208-001-50 D-0017-2023
Class II · Moderate risk

Proton Armor

Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.

Terminated Chemical / undeclared Ultra Chem Labs Corp NDC 79208-001-50 D-0016-2023
Class II · Moderate risk

PF-Labetalol HCl Injection

CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Terminated Cross-contamination Nephron Sterile Compounding Center LLC NDC 69374-946-34 D-1347-2022
Class II · Moderate risk

PF-0.125% Bupivacaine HCl Injection

CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Terminated Cross-contamination Nephron Sterile Compounding Center LLC NDC 69374-970-05 D-1346-2022
Class II · Moderate risk

Trisodium Citrate 0.5% Solution

CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Terminated Cross-contamination Nephron Sterile Compounding Center LLC NDC 69374-910-04 D-1345-2022
Class II · Moderate risk

Acetaminophen Injection

Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment.

Terminated Temperature excursion Baxter Healthcare Corporation NDC 36000-306-60 D-1348-2022
Class II · Moderate risk

Rifampin Capsules

CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.

Terminated Nitrosamine impurity Lupin Pharmaceuticals Inc. D-1343-2022

Recalls by year